Japanese drugmaker gets US antitrust case sent to arbitration
Credit: Shutterstock/IM Imagery
A Japanese drugmaker has won its bid to compel AAA arbitration of a complaint that it broke antitrust laws by paying to delay the launch of a generic version of a laxative.
To read more
Subscribe to Global Arbitration Review
Register for limited access
Register for free to receive GAR’s daily briefing and access to GAR 100.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.
Subscribe now